March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
An Angiogenic Role Of Adrenomedullin In Choroidal Neovascularization
Author Affiliations & Notes
  • Susumu Sakimoto
    Ophthalmology, Osaka University Graduate School of Medicine, Suita, Japan
  • Motohiro Kamei
    Ophthalmology, Osaka University Graduate School of Medicine, Suita, Japan
  • Hiroyasu Kidoya
    Signal Transduction, Research Institute for Microbial Diseases, Osaka University, Suita, Japan
  • Hisamichi Naito
    Signal Transduction, Research Institute for Microbial Diseases, Osaka University, Suita, Japan
  • Nagakazu Matsumura
    Ophthalmology, Osaka University Graduate School of Medicine, Suita, Japan
  • Mihoko Suzuki
    Ophthalmology, Osaka University Graduate School of Medicine, Suita, Japan
  • Hirokazu Sakaguchi
    Ophthalmology, Osaka University Graduate School of Medicine, Suita, Japan
  • Nobuyuki Takakura
    Signal Transduction, Research Institute for Microbial Diseases, Osaka University, Suita, Japan
  • Kohji Nishida
    Ophthalmology, Osaka University Graduate School of Medicine, Suita, Japan
  • Footnotes
    Commercial Relationships  Susumu Sakimoto, None; Motohiro Kamei, None; Hiroyasu Kidoya, None; Hisamichi Naito, None; Nagakazu Matsumura, None; Mihoko Suzuki, None; Hirokazu Sakaguchi, None; Nobuyuki Takakura, None; Kohji Nishida, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 5827. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Susumu Sakimoto, Motohiro Kamei, Hiroyasu Kidoya, Hisamichi Naito, Nagakazu Matsumura, Mihoko Suzuki, Hirokazu Sakaguchi, Nobuyuki Takakura, Kohji Nishida; An Angiogenic Role Of Adrenomedullin In Choroidal Neovascularization. Invest. Ophthalmol. Vis. Sci. 2012;53(14):5827.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Adrenomedullin (ADM) takes part in physiologic and pathologic angiogenesis. This study investigated if ADM signaling is involved in choroidal neovascularization (CNV) in a mouse model.

Methods: : CNV was induced by laser photocoagulation in 8-week-old C57BL/6 mice. ADM mRNA expression in the choroid-RPE complex was evaluated by quantitative RT-PCR (qPCR) on days 0, 2, 4, 7 after laser treatment (n=3, respectively). To confirm the expression of ADM receptor (ADM-R) component (CRLR, RAMP2 and RAMP3) in vascular endothelial cells (ECs), we performed qPCR on CD31+ CD45- cells that were sorted from laser treated or non-treated eye (n=8). We also evaluated the effect of ADM antagonist, ADM (22-52) in laser-induced CNV. We intravitreously injected 0.1 or 1mM ADM (22-52) or vehicle on days 0 and 3 after laser treatment and assessed the CNV size with choroidal flat-mount immunochemical staining for CD31 on day 7 (n=16).

Results: : The amount of CRLR, RAMP2 and RAMP3 mRNA were more than three times higher in CD31+ CD45- ECs than CD31- CD45- non-ECs, while no significant difference was detected between the laser treated and non-treated group. In contrast, ADM mRNA expression significantly increased after laser treatment, peaking at 4 days after treatment. The mean CNV sizes in 0.1mM ADM (22-52), 1mM ADM (22-52) and vehicle-treated eyes were 22040, 35953, and 42314 μm2, respectively. Intravitreal injection of 1mM ADM (22-52) significantly reduced the CNV size compared with vehicle-treated control eyes (p<0.001).

Conclusions: : ADM signaling was involved in CNV formation, i.e., ADM-R expression was higher in ECs compared with non-ECs and ADM expression increased during CNV formation. Moreover, the ADM antagonist significantly inhibited CNV formation. Suppression of ADM signaling might be a valuable alternative treatment for CNV associated with age-related macular degeneration.

Keywords: choroid: neovascularization • retina • age-related macular degeneration 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×